Trinity Jude Bivalacqua
#142,721
Most Influential Person Now
Trinity Jude Bivalacqua's AcademicInfluence.com Rankings
Trinity Jude Bivalacquaphilosophy Degrees
Philosophy
#7519
World Rank
#10743
Historical Rank
Logic
#4570
World Rank
#5880
Historical Rank
Download Badge
Philosophy Biology
Trinity Jude Bivalacqua's Degrees
- Bachelors Biology University of Maryland, College Park
- Doctorate Medicine Johns Hopkins University
- Masters Public Health Johns Hopkins University
Similar Degrees You Can Earn
Why Is Trinity Jude Bivalacqua Influential?
(Suggest an Edit or Addition)Trinity Jude Bivalacqua's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Neurohumoral features of myocardial stunning due to sudden emotional stress. (2005) (2910)
- Priapism: pathogenesis, epidemiology, and management. (2010) (275)
- Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. (2003) (269)
- Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. (2006) (251)
- RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction (2004) (248)
- Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. (2003) (244)
- Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. (2009) (239)
- Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. (2005) (228)
- Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. (2015) (227)
- 18F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer (2015) (176)
- Peyronie's disease: etiology, medical, and surgical therapy. (2000) (161)
- Evidence-Based Management Guidelines on Peyronie's Disease. (2016) (153)
- Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. (2001) (149)
- Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. (2007) (141)
- Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma. (2015) (132)
- Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. (2005) (131)
- Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease. (2013) (129)
- The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men. (2015) (125)
- Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. (2003) (123)
- The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder (2016) (122)
- Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. (2006) (122)
- Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. (2017) (119)
- Gene transfer of extracellular SOD to the penis reduces O2-* and improves erectile function in aged rats. (2003) (116)
- Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. (2006) (116)
- Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy (2018) (114)
- A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. (2000) (114)
- Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. (2020) (110)
- Priapism: current principles and practice. (2007) (110)
- Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Effect on agonist-induced and flow-mediated vascular responses. (1999) (106)
- Elevated RhoA/Rho‐kinase activity in the aged rat penis: mechanism for age‐associated erectile dysfunction (2006) (104)
- Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. (1999) (104)
- Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification tools. (2015) (98)
- Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase. (2007) (98)
- In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse. (2000) (95)
- Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction (2002) (95)
- Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice (2002) (91)
- Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy. (2016) (87)
- Very high risk localized prostate cancer: definition and outcomes (2013) (86)
- Patient and partner satisfaction and long-term results after surgical treatment for Peyronie's disease. (2003) (86)
- Nightly vs on‐demand sildenafil for penile rehabilitation after minimally invasive nerve‐sparing radical prostatectomy: results of a randomized double‐blind trial with placebo (2013) (86)
- Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study (2017) (84)
- Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis. (2007) (82)
- Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG (2015) (82)
- Standard operating procedure for the preservation of erectile function outcomes after radical prostatectomy. (2013) (80)
- Gene Transfer of Prepro-Calcitonin Gene-Related Peptide Restores Erectile Function in the Aged Rat1 (2001) (78)
- Prostate Specific Membrane Antigen Targeted 18F‐DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study (2018) (74)
- Pharmacotherapy for erectile dysfunction. (2000) (73)
- Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials (2019) (72)
- Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer (2017) (71)
- Cardioprotection with sildenafil, a selective inhibitor of cyclic 3',5'-monophosphate-specific phosphodiesterase 5. (2002) (69)
- Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats (2004) (68)
- Understanding and targeting the Rho kinase pathway in erectile dysfunction (2014) (68)
- Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry. (2018) (68)
- Management of priapism: an update for clinicians (2014) (66)
- Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy of Non-muscle Invasive Bladder Cancer. (2019) (66)
- Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. (2009) (64)
- Priapism: new concepts in medical and surgical management. (2011) (63)
- A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease. (1999) (61)
- The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment. (2006) (61)
- New insights into the pathophysiology of sickle cell disease-associated priapism. (2012) (61)
- Inhibition of Rho-kinase improves erectile function, increases nitric oxide signaling and decreases penile apoptosis in a rat model of cavernous nerve injury. (2013) (60)
- Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3‐4aN0M0 Bladder Cancer Treated with Radical Cystectomy (2018) (60)
- The protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats. (2003) (59)
- New Strategies in Bladder Cancer: A Second Coming for Immunotherapy (2015) (59)
- Sildenafil inhibits superoxide formation and prevents endothelial dysfunction in a mouse model of secondhand smoke induced erectile dysfunction. (2009) (58)
- The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy. (2012) (58)
- Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer (2017) (58)
- Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen. (2010) (58)
- Activated RhoA/Rho kinase impairs erectile function after cavernous nerve injury in rats. (2010) (57)
- A comparison of the NADPH oxidase in human sperm and white blood cells. (2002) (57)
- Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie's disease. (2004) (57)
- Sildenafil Citrate-Restored eNOS and PDE5 Regulation in Sickle Cell Mouse Penis Prevents Priapism Via Control of Oxidative/Nitrosative Stress (2013) (56)
- Adenoviral gene transfer of eNOS: high-level expression in ex vivo expanded marrow stromal cells. (2003) (55)
- Endothelial nitric oxide synthase regulation in female genital tract structures. (2009) (55)
- Molecular Characterization of Neuroendocrine-like Bladder Cancer (2019) (53)
- Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30‐year experience (2013) (52)
- Radial forearm free flap phalloplasty for penile inadequacy in patients with exstrophy. (2013) (52)
- A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157 (2016) (51)
- Priapism: New concepts in the pathophysiology and new treatment strategies (2006) (51)
- Intravesical BCG Induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer (2017) (50)
- Stratification of penile vascular pathologies in patients with Peyronie's disease and in men with erectile dysfunction according to age: a comparative study. (2004) (49)
- Hospital Charges and Length of Stay Following Radical Cystectomy in the Enhanced Recovery After Surgery Era. (2018) (48)
- Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy. (2013) (47)
- Predictive biomarkers for drug response in bladder cancer (2019) (47)
- Three-dimensional organoid culture reveals involvement of Wnt/β-catenin pathway in proliferation of bladder cancer cells (2018) (47)
- Role of Cyclooxygenase-2 in the Generation of Vasoactive Prostanoids in the Rat Pulmonary and Systemic Vascular Beds (2003) (47)
- Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma (2018) (46)
- Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort. (2017) (46)
- Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018 (2019) (46)
- Involvement of Epigenetics and EMT-Related miRNA in Arsenic-Induced Neoplastic Transformation and Their Potential Clinical Use (2015) (46)
- Contemporaneous comparison of open vs minimally‐invasive radical prostatectomy for high‐risk prostate cancer (2013) (45)
- 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19 (2021) (44)
- Corporal Burnett "Snake" surgical maneuver for the treatment of ischemic priapism: long-term followup. (2013) (44)
- Glucose-6-phosphate dehydrogenase deficiency: an etiology for idiopathic priapism? (2008) (44)
- Landmarks in erectile function recovery after radical prostatectomy (2015) (44)
- Utility of uroplakin II expression as a marker of urothelial carcinoma. (2015) (43)
- Open, laparoscopic and robotic radical prostatectomy: optimizing the surgical approach. (2009) (43)
- Posttranslational modification of constitutive nitric oxide synthase in the penis. (2009) (43)
- Combined inflatable penile prosthesis-artificial urinary sphincter implantation: no increased risk of adverse events compared to single or staged device implantation. (2013) (43)
- Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction. (2016) (43)
- Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma (2015) (42)
- Adipose-derived Stem Cells Counteract Urethral Stricture Formation in Rats. (2016) (41)
- Engineering Ex Vivo–Expanded Marrow Stromal Cells to Secrete Calcitonin Gene–Related Peptide Using Adenoviral Vector (2004) (41)
- A Phase I Study to Assess the Safety and Cancer‐Homing Ability of Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer (2019) (41)
- Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate‐risk to very‐high‐risk clinically localised prostate cancer (2019) (41)
- Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance. (2012) (41)
- Medical management of ischemic stuttering priapism: a contemporary review of the literature. (2012) (40)
- Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of Care (2017) (40)
- Xanthogranulomatous pyelonephritis: presentation and management in the era of laparoscopy (2009) (40)
- Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816). (2020) (40)
- Gene therapy for erectile dysfunction: fact or fiction? (2006) (40)
- Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. (2002) (39)
- Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non–Muscle-Invasive Bladder Cancer (2017) (39)
- Attenuated RhoA/Rho-kinase signaling in penis of transgenic sickle cell mice. (2010) (39)
- Valproic acid prevents penile fibrosis and erectile dysfunction in cavernous nerve-injured rats. (2014) (39)
- Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis. (2014) (39)
- Potential application of gene therapy for the treatment of erectile dysfunction. (2001) (38)
- Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat (1998) (38)
- Immunotherapy with Checkpoint Blockade in the Treatment of Urothelial Carcinoma (2017) (38)
- Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer. (2009) (38)
- Emerging tools for erectile dysfunction: a role for regenerative medicine (2012) (38)
- Quantifying Nonindex Hospital Readmissions and Care Fragmentation after Major Urological Oncology Surgeries in a Nationally Representative Sample (2017) (37)
- Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas. (2015) (37)
- Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction. (2015) (37)
- Urinary outcomes are significantly affected by nerve sparing quality during radical prostatectomy. (2013) (36)
- Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors. (2019) (36)
- Nitric oxide/redox-based signalling as a therapeutic target for penile disorders (2006) (36)
- The influence of castration on pharmacologically induced penile erection in the cat. (1998) (35)
- High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma (2016) (35)
- Erythropoietin promotes erection recovery after nerve-sparing radical retropubic prostatectomy: a retrospective analysis. (2008) (35)
- Penile ischemic injury in the exstrophy/epispadias spectrum: new insights and possible mechanisms. (2010) (35)
- Penile transplantation: an emerging option for genitourinary reconstruction (2017) (35)
- Intralesional Interferon-&agr;-2B Injections for the Treatment of Peyronie’s Disease (2004) (35)
- Arginase Inhibition Reverses Endothelial Dysfunction, Pulmonary Hypertension, and Vascular Stiffness in Transgenic Sickle Cell Mice (2016) (34)
- Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder. (2016) (34)
- Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes. (2015) (34)
- High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder (2016) (34)
- Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. (2020) (34)
- Standard operational procedures for low sexual desire in men. (2013) (34)
- Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4). (1999) (34)
- Gene therapy techniques for the delivery of endothelial nitric oxide synthase to the corpora cavernosa for erectile dysfunction. (2004) (34)
- Ureteral Stents Placed at the Time of Urinary Diversion Decreases Postoperative Morbidity (2012) (34)
- Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center. (2012) (33)
- Dysregulation of cGMP‐dependent protein kinase 1 (PKG‐1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1α (2007) (33)
- Chronic oral administration of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) improves erectile function in aged rats. (2012) (32)
- Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction. (2009) (32)
- A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression1 (2018) (32)
- Poly(Adenosine diphosphate-ribose) polymerase inhibition preserves erectile function in rats after cavernous nerve injury. (2005) (31)
- Caspase-3 dependent nitrergic neuronal apoptosis following cavernous nerve injury is mediated via RhoA and ROCK activation in major pelvic ganglion (2016) (31)
- Incidence and Distribution of UroSEEK Gene Panel in a Multi-institutional Cohort of Bladder Urothelial Carcinoma (2019) (30)
- Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder. (2016) (30)
- Urinary Tissue Engineering: Challenges and Opportunities. (2018) (30)
- Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity. (2011) (29)
- Vasoactive prostanoids are generated from arachidonic acid by COX-1 and COX-2 in the mouse. (2005) (29)
- Endothelial nitric oxide synthase gene therapy for erectile dysfunction. (2005) (29)
- Role of genitourinary inflammation in infertility: synergistic effect of lipopolysaccharide and interferon-gamma on human spermatozoa. (2001) (29)
- Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy (2016) (29)
- Tissue-Engineered Urinary Conduits (2015) (28)
- Regenerative and engineered options for urethroplasty (2019) (28)
- Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations. (2019) (28)
- Role of calcitonin gene-related peptide (CGRP) in chronic hypoxia-induced pulmonary hypertension in the mouse Influence of gene transfer in vivo (2002) (28)
- Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012). (2016) (28)
- Penile Allotransplantation for Complex Genitourinary Reconstruction (2017) (27)
- Endothelium-specific gene and stem cell-based therapy for erectile dysfunction. (2008) (27)
- Gene and stem cell therapy for erectile dysfunction (2005) (27)
- The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy. (2019) (27)
- Pathophysiology of erectile dysfunction. (2015) (27)
- Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer (2019) (27)
- Robotic surgery in urological oncology: patient care or market share? (2015) (27)
- Inflatable penile prosthesis technique and outcomes after radial forearm free flap neophalloplasty (2014) (27)
- Ex Vivo Model of Human Penile Transplantation and Rejection: Implications for Erectile Tissue Physiology. (2017) (26)
- Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder (2017) (26)
- Role Of Nitric Oxide In Mediating Vasodilator Responses To Opioid Peptides In The Rat (2002) (26)
- Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes (2021) (26)
- Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT? (2017) (26)
- Expression of a Distinct Set of Chemokine Receptors in Adipose Tissue-Derived Stem Cells is Responsible for In Vitro Migration Toward Chemokines Appearing in the Major Pelvic Ganglion Following Cavernous Nerve Injury (2013) (26)
- Predictors of improved survival for patients with retroperitoneal sarcoma. (2016) (26)
- ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer (2018) (26)
- ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder. (2014) (25)
- Identification of men with the highest risk of early disease recurrence after radical prostatectomy (2014) (25)
- Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease (2002) (24)
- Arginase inhibition promotes wound healing in mice. (2012) (24)
- Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma (2017) (24)
- A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer. (2016) (24)
- Superoxide dismutase - a target for gene therapeutic approach to reduce oxidative stress in erectile dysfunction. (2010) (24)
- The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment (2004) (24)
- Beneficial Effect of the Nitric Oxide Donor Compound 3-(1,3-Dioxoisoindolin-2-yl)Benzyl Nitrate on Dysregulated Phosphodiesterase 5, NADPH Oxidase, and Nitrosative Stress in the Sickle Cell Mouse Penis: Implication for Priapism Treatment (2016) (24)
- Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer. (2019) (24)
- Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences. (2020) (23)
- CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer (2018) (23)
- Total Penis, Scrotum, and Lower Abdominal Wall Transplantation. (2019) (23)
- Stem Cell Therapy for Erectile Dysfunction: Progress and Future Directions. (2013) (22)
- Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy. (2014) (22)
- Intratunical Injection of Human Adipose Tissue–Derived Stem Cells Restores Collagen III/I Ratio in a Rat Model of Chronic Peyronie’s Disease (2018) (21)
- GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin. (2014) (21)
- In-hospital death and hospital-acquired complications among patients undergoing partial cystectomy for bladder cancer in the United States. (2014) (21)
- Whole genome microarray of the major pelvic ganglion after cavernous nerve injury: new insights into molecular profile changes after nerve injury (2012) (21)
- Peroxynitrite does not impair pulmonary and systemic vascular responses. (2004) (21)
- Effects of PKC isozyme inhibitors on constrictor responses in the feline pulmonary vascular bed. (2001) (21)
- Temporal changes in neurotrophic factors and neurite outgrowth in the major pelvic ganglion following cavernous nerve injury (2015) (20)
- Responses to human CGRP, ADM, and PAMP in human thymic arteries. (2003) (20)
- Perioperative betamethasone treatment reduces signs of bladder dysfunction in a rat model for neurapraxia in female urogenital surgery. (2012) (20)
- Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference (2016) (20)
- Ureteral and urethral frozen sections during radical cystectomy or cystoprostatectomy: an analysis of denudation and atypia. (2014) (20)
- Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy (2017) (20)
- The good, bad, and the ugly of regenerative therapies for erectile dysfunction (2020) (20)
- Comparing Provider-Led Sexual Health Counseling of Male and Female Patients Undergoing Radical Cystectomy. (2020) (20)
- Mechanistic link between erectile dysfunction and systemic endothelial dysfunction in type 2 diabetic rats (2016) (20)
- Surgical Factors Associated With Male and Female Sexual Dysfunction After Radical Cystectomy: What Do We Know and How Can We Improve Outcomes? (2018) (20)
- Endomorphin 1 and 2, the endogenous mu-opioid agonists, produce biphasic changes in systemic arterial pressure in the cat. (1998) (19)
- Accuracy of urethral frozen section during radical cystectomy for bladder cancer. (2016) (19)
- Metabolomics and bladder cancer. (2011) (19)
- Common pitfalls in some of the experimental studies in erectile function and dysfunction: a consensus article. (2012) (19)
- Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. (2019) (19)
- Acute Ischemic Priapism: An AUA/SMSNA Guideline (2021) (19)
- The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia (2021) (19)
- Analysis of responses to hAmylin, hCGRP, and hADM in isolated resistance arteries from the mesenteric vascular bed of the rat (2001) (19)
- Peyronie’s disease: Advances in basic science and pathophysiology (2000) (19)
- Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine (2014) (19)
- An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine (2014) (19)
- Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer (2022) (18)
- Localization of peripheral dopamine D1 and D2 receptors in rat and human seminal vesicles. (2002) (18)
- Impact of hospital volume on perioperative outcomes and costs of radical cystectomy: analysis of the Maryland Health Services Cost Review Commission database. (2014) (18)
- Urinary cytology and the Paris system for reporting urinary cytology: Implications for urological management (2018) (18)
- Outcomes of men with an elevated prostate‐specific antigen (PSA) level as their sole preoperative intermediate‐ or high‐risk feature (2014) (18)
- Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases. (2005) (18)
- Cavernous Nerve Injury by Radiation Therapy May Potentiate Erectile Dysfunction in Rats. (2017) (18)
- Post-translational inactivation of endothelial nitric oxide synthase in the transgenic sickle cell mouse penis. (2011) (18)
- Proadrenomedullin NH2-terminal 20 peptide has cAMP-mediated vasodilator activity in the mesenteric vascular bed of the cat (1996) (18)
- Programmed Cell Death Ligand-1 Blockade in Urothelial Bladder Cancer: To Select or Not to Select. (2016) (18)
- Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network. (2018) (18)
- Extent of pelvic lymph node dissection during radical cystectomy: is bigger better? (2014) (17)
- Immune checkpoint inhibitors: a new frontier in bladder cancer (2015) (17)
- Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial. (2020) (17)
- A Systematic Review on Ischemic Priapism and Immediate Implantation: Do We Need More Data? (2019) (17)
- Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation. (2011) (17)
- Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA) (2021) (17)
- Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium. (2020) (17)
- Additive effects of the Rho kinase inhibitor Y‐27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure (2017) (17)
- M1 Macrophages Are Predominantly Recruited to the Major Pelvic Ganglion of the Rat Following Cavernous Nerve Injury. (2017) (17)
- Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunction (2004) (17)
- 806 INTRATUNICAL INJECTION OF HUMAN ADIPOSE TISSUE-DERIVED STEM CELLS PREVENTS FIBROSIS AND IS ASSOCIATED WITH IMPROVED ERECTILE FUNCTION IN A RAT MODEL OF PEYRONIE'S DISEASE (2013) (16)
- Analysis of Vasodilator Responses to Peroxynitrite in the Hindlimb Vascular Bed of the Cat (2007) (16)
- Intralesional interferon-alpha-2B injections for the treatment of Peyronie's disease. (2004) (16)
- Induction of penile erection by intracavernosal and transurethral administration of novel nitric oxide donors in the cat. (1999) (16)
- Irbesartan promotes erection recovery after nerve‐sparing radical retropubic prostatectomy: a retrospective long‐term analysis (2012) (16)
- Corrigendum to “Intratunical Injection of Human Adipose Tissue–derived Stem Cells Prevents Fibrosis and Is Associated with Improved Erectile Function in a Rat Model of Peyronie's Disease” [Eur Urol 2013;63:551–60] (2013) (16)
- Biomanufacturing Seamless Tubular and Hollow Collagen Scaffolds with Unique Design Features and Biomechanical Properties (2017) (15)
- Paraneoplastic polyarthritis from non-small-cell lung cancer metastatic to the bladder. (2007) (15)
- Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation. (2015) (15)
- Increased expression of the neuroregenerative peptide galanin in the major pelvic ganglion following cavernous nerve injury. (2014) (15)
- Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy? (2016) (15)
- Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method. (2017) (15)
- Lymph node density predicts recurrence and death after inguinal lymph node dissection for penile cancer (2017) (15)
- Predictors of local recurrence and its impact on survival after glansectomy for penile cancer: time to challenge the dogma? (2020) (15)
- Immune response results of vesigenurtacel-l (HS-410) in combination with BCG from a randomized phase II trial in patients with non-muscle invasive bladder cancer (NMIBC). (2017) (14)
- Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection (2015) (14)
- Patient‐reported outcomes of blue‐light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study (2018) (14)
- Penile prosthetic trends in the era of effective oral erectogenic agents. (2000) (14)
- Penile straightening maneuvers employed during penile prosthesis surgery: technical options and outcomes (2014) (14)
- Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease (2008) (14)
- Sexual Function and Quality of Life Before and After Penile Prosthesis Implantation Following Radial Forearm Flap Phalloplasty. (2017) (14)
- Intratunical injection of stromal vascular fraction prevents fibrosis in a rat model of Peyronie's disease (2019) (14)
- An evaluation of monthly maintenance therapy among patients receiving intravesical combination gemcitabine/docetaxel for nonmuscle-invasive bladder cancer. (2020) (13)
- The utility of an extensive postchemotherapy staging evaluation in patients receiving neoadjuvant chemotherapy for bladder cancer. (2014) (13)
- Tumor immune microenvironment in non-muscle invasive urothelial carcinoma of bladder. (2019) (13)
- Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study. (2021) (13)
- A Case Report of Primary Recurrent Malignant Melanoma of the Urinary Bladder (2013) (13)
- Ex vivo culture of tumor cells from N-methyl-N-nitrosourea-induced bladder cancer in rats: Development of organoids and an immortalized cell line. (2018) (13)
- The impact of preoperative erectile dysfunction on survival after radical prostatectomy (2010) (13)
- Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer. (2020) (13)
- International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladder Cancer. (2021) (13)
- Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancer. (2019) (12)
- The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers (2021) (12)
- Multimodal Therapy in the Treatment of Prostate Sarcoma: The Johns Hopkins Experience. (2015) (12)
- Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims Database. (2017) (12)
- GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma (2020) (12)
- Impaired contraction and decreased detrusor innervation in a female rat model of pelvic neuropraxia (2017) (11)
- Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20‐year institutional experience (2013) (11)
- Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology (2019) (11)
- Tissue-Engineered Neo-Urinary Conduit from Decellularized Trachea. (2018) (11)
- Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder Cancer. (2017) (11)
- Gene therapy techniques for the delivery of endothelial nitric oxide synthase to the lung for pulmonary hypertension. (2010) (11)
- Sickle Cell Disease in Priapism: Disparity in Care? (2015) (11)
- Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats. (2001) (11)
- Inhibition of sympathetic neuroeffector transmission in human corpus cavernosum (2012) (11)
- Role of AT(1) receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice. (1999) (11)
- Early-stage Type 2 Diabetes Mellitus Impairs Erectile Function and Neurite Outgrowth From the Major Pelvic Ganglion and Downregulates the Gene Expression of Neurotrophic Factors. (2017) (11)
- The Use of Regenerative Medicine in the Management of Invasive Bladder Cancer (2012) (10)
- Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy (2018) (10)
- Diagnosing and Treating Inflammatory Myofibroblastic Tumor of the Bladder (2016) (10)
- POTENTIAL ROLE OF NUCLEAR FACTOR-kappa B IN THE INDUCTION OF PEYRONIE'S-LIKE CONDITION IN THE RAT (1999) (10)
- Feline penile erection induced by topical glans penis application of combination alprostadil and SEPA (Topiglan) (2004) (10)
- 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one (2016) (10)
- Intratunical injection of autologous adipose stromal vascular fraction reduces collagen III expression in a rat model of chronic penile fibrosis (2019) (10)
- 1202: Long-Term Phosphodiesterase Type 5 Inhibitor Therapy Reduces Priapic Activity in Transgenic Sickle Cell Mice (2006) (10)
- Use of regenerative tissue for urinary diversion (2015) (10)
- Low-intensity extracorporeal shockwave therapy in the treatment of erectile dysfunction following radical prostatectomy: a critical review (2019) (10)
- S1605: Phase II trial of atezolizumab in BCG-unresponsive nonmuscle invasive bladder cancer. (2017) (10)
- Analysis of Vasodilator Responses to Novel Nitric Oxide Donors in the Hindquarters Vascular Bed of the Cat (2001) (9)
- Phase II neoadjuvant and immunologic study of B7-H3 targeting with enoblituzumab in localized intermediate- and high-risk prostate cancer. (2018) (9)
- High-dose-rate intraoperative radiation therapy: the nuts and bolts of starting a program (2014) (9)
- Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture (2021) (9)
- Longer average blood storage duration is associated with increased risk of infection and overall morbidity following radical cystectomy. (2017) (9)
- 178 Pre-clinical and clinical translation of a tissue engineered neo–urinary conduit using adipose derived smooth muscle cells for urinary reconstruction (2014) (9)
- Feline penile erection induced by transurethral administration of sodium nitroprusside (1999) (9)
- Analysis of vasoconstrictor responses to histamine in the hindlimb vascular bed of the rabbit. (1999) (9)
- Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer (2019) (9)
- Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy (2018) (9)
- Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG. (2021) (9)
- Organoid culture of bladder cancer cells (2018) (9)
- Mini Review: Pathophysiology of Erectile Dysfunction. (2015) (9)
- Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression. (2016) (9)
- Recombinant BCG overexpressing a STING agonist elicits trained immunity and improved antitumor efficacy in non-muscle invasive bladder cancer (2020) (8)
- A Molecular Inquiry into the Role of Antibody-Drug Conjugates in Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer. (2021) (8)
- Vasodilator responses to adenosine and hyperemia are mediated by A(1) and A(2) receptors in the cat vascular bed. (2002) (8)
- Analysis of Hospital Readmissions After Prosthetic Urologic Surgery in the United States: Nationally Representative Estimates of Causes, Costs, and Predictive Factors. (2017) (8)
- Hospitalisation and readmission costs after radical cystectomy in a nationally representative sample: does urinary reconstruction matter? (2018) (8)
- Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. (2022) (8)
- Intraperitoneal effects of extraperitoneal laparoscopic radical prostatectomy. (2008) (8)
- Post-translational regulation of endothelial nitric oxide synthase (eNOS) by estrogens in the rat vagina. (2010) (8)
- The use of gene transfer technology to study the pathophysiology of erectile dysfunction. (2008) (8)
- A phase II trial of risk-adapted treatment for muscle invasive bladder cancer after neoadjuvant accelerated MVAC. (2018) (8)
- The influence of candesartan and PD123319 on responses to angiotensin II in the hindquarters vascular bed of the rat. (1999) (8)
- Effects of candesartan and PD123319 on responses to angiotensin II in the anesthetized mouse. (1999) (8)
- Characterization of voiding function and structural bladder changes in a rat model of neurogenic underactive bladder disease (2018) (7)
- Nitric oxide-mediated erectile effects of galantide but not galanin in vivo. (2000) (7)
- Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study. (2021) (7)
- [Tyr1]-nociceptin and nociceptin have similar naloxone-insensitive erectile activity in the cat. (1998) (7)
- Comparative responses to α,β-methylene-ATP in cat pulmonary, mesenteric, and hindquarter vascular beds (2002) (7)
- Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer (2021) (7)
- Immunotherapy in nonmuscle invasive bladder cancer: current and emerging treatments (2019) (7)
- Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis (2020) (7)
- Current penile-rehabilitation strategies: Clinical evidence (2013) (7)
- Impact of spheroid culture on molecular and functional characteristics of bladder cancer cell lines. (2019) (7)
- Comparison of Responses to T-Kinin and Bradykinin in the Mesenteric Vascular Bed of the Cat (1997) (7)
- Favorable response to neoadjuvant chemotherapy and radiation in a patient with prostatic stromal sarcoma. (2012) (7)
- An Empirical vs Risk-Based Approach Algorithm to Intracavernosal Injection Therapy: A Prospective Study (2017) (7)
- MP78-10 INACCURACY OF CLINICAL STAGING AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER (2018) (6)
- Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma. (2020) (6)
- Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder Cancer. (2019) (6)
- Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy. (2015) (6)
- Bladder cancer and the aluminium industry: a review (2008) (6)
- Infectious complications in transfused patients after radical cystectomy. (2016) (6)
- Galanin Administration Partially Restores Erectile Function After Cavernous Nerve Injury and Mediates Endogenous Nitrergic Nerve Outgrowth In Vitro. (2018) (6)
- Aliphatic Chain Modification of Collagen Type I: Development of Elastomeric, Compliant, and Suturable Scaffolds (2020) (6)
- Management of primary squamous cell carcinoma at the mucocutaneous junction of an ileal conduit. (2011) (6)
- Understanding psychosocial and sexual health concerns among women with bladder cancer undergoing radical cystectomy. (2020) (6)
- Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease. (2020) (6)
- Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer. (2021) (6)
- Oncological outcomes of intravesical gemcitabine and docetaxel for select patients with high grade recurrent NMIBC. (2017) (5)
- A Genomic Classifier for Predicting Clinically Aggressive Luminal Bladder Tumors with Higher Rates of Pathological Upstaging. (2020) (5)
- Erratum: Identification and validation of protein biomarkers of response to neoadjuvant platinum chemotherapy in muscle invasive urothelial carcinoma (PLoS ONE (2015) 10:7 (e0131245) (DOI:10.1371/journal.pone.0131245)) (2015) (5)
- Diagnosis of urothelial carcinoma in situ using blue light cystoscopy and the utility of immunohistochemistry in blue light-positive lesions diagnosed as atypical. (2019) (5)
- Recombinant BCGs for tuberculosis and bladder cancer. (2021) (5)
- Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma (2020) (5)
- Erratum: The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment (BJU International (2004) 94 (429-432)) (2004) (5)
- Molecular science of priapism (2007) (5)
- Innumerable Condyloma Acuminatum Tumors of the Bladder (2017) (5)
- Evaluation of gender‐based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database (2017) (5)
- Penile Allotransplantation: Pushing the Limits. (2019) (5)
- RhoA/ROCK activation in major pelvic ganglion mediates caspase-3 dependent nitrergic neuronal apoptosis following cavernous nerve injury (2017) (5)
- Non-invasive detection of bladder cancer through the analysis of driver gene mutations and aneuploidy (2017) (5)
- Reduction of Costs for Pelvic Exenteration Performed by High Volume Surgeons: Analysis of the Maryland Health Service Cost Review Commission Database (2016) (5)
- Adjuvant radiation for node-positive disease after prostatectomy: more good news, but who will listen? (2014) (5)
- Analysis of the effects of candesartan on responses to angiotensin II in the hindquarters vascular bed of the cat. (1999) (5)
- Postoperative complications following intraoperative radiotherapy in abdominopelvic malignancy: A single institution analysis of 113 consecutive patients (2017) (5)
- Role of AT1 receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice. (1999) (5)
- Nightly sildenafil use after radical prostatectomy has adverse effects on urinary convalescence: Results from a randomized trial of nightly vs on-demand dosing regimens. (2015) (5)
- PD31-12 PDL1 STATUS IN MUSCLE INVASIVE UROTHELIAL BLADDER CARCINOMA (MIBC) IN THE CONTEXT OF NEOADJUVANT CISPLATIN BASED CHEMOTHERAPY (2015) (4)
- Application of Evicel to cavernous nerves of the rat does not influence erectile function in vivo. (2008) (4)
- A Nationally Representative Study of Non-Index Hospital Readmissions Following Radical Prostatectomy: Implications for Bundled Payment Models. (2019) (4)
- Evaluation of Incisional Negative Pressure Wound Therapy in the Prevention of Surgical Site Occurrences After Radical Cystectomy: A New Addition to Enhanced Recovery After Surgery Protocol. (2019) (4)
- Phosphodiesterase type 5 inhibitor therapy for priapism (2008) (4)
- Contemporary Assessment of the Most Cited Clinical, Basic Science, and Guidelines Papers in Urology: A Reference for Urology Journal Club. (2020) (4)
- Comparison of Biochemical Recurrence–Free Survival Between Periprostatic and Pelvic Lymph Node Metastases of Prostate Cancer (2013) (4)
- Single-cell Transcriptomics Uncover a Novel Role of Myeloid Cells and T-lymphocytes in the Fibrotic Microenvironment in Peyronie's Disease. (2021) (4)
- Reply from Authors re: Ching-Shwun Lin, Tom F. Lue. Adipose-derived Stem Cells for the Treatment of Peyronie's Disease? Eur Urol 2013;63:561-2: Xenogeneic Adipose Stem Cell Treatment in a Rat Model of Peyronie's Disease. (2013) (4)
- The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-Ischemic Priapism: An AUA/SMSNA Guideline (2022) (4)
- Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and Survival (2021) (4)
- Identification of Candidates for Salvage Therapy: The Past, Present, and Future of Defining Bacillus Calmette-Guérin Failure. (2020) (4)
- Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (2021) (4)
- PD17-06 RANDOMIZED PHASE II TRIAL OF INTRAVESICAL ADENOVIRAL MEDIATED INTERFERON-α GENE THERAPY WITH THE EXCIPIENT SYN3 (RAD-IFNα/SYN3) IN PATIENTS WITH BCG REFRACTORY OR RELAPSING HIGH GRADE (HG) NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) (2015) (4)
- BLUE LIGHT FLEXIBLE CYSTOSCOPY (BLFC) WITH HEXAMINOLEVULINATE (HAL) AND WHITE LIGHT FLEXIBLE CYSTOSCOPY: A PROSPECTIVE, COMPARATIVE, WITHIN‐PATIENT CONTROLLED MULTI‐CENTER PHASE 3 STUDY IN THE DETECTION OF BLADDER CANCER DURING SURVEILLANCE: PPTLBA‐02 (2017) (4)
- LONG-TERM SURVIVAL AFTER RADICAL PROSTATECTOMY FOR MEN WITH HIGH PATHOLOGIC GLEASON SUM (2009) (4)
- What Is the Future of Erectile Dysfunction Therapy? (2018) (4)
- Regenerative medicine in urology: the future of urinary reconstruction (2020) (3)
- Molecular Profile of Priapism Associated with Low Nitric Oxide Bioavailability. (2018) (3)
- Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical Outcome. (2020) (3)
- Increased Level of Tumor Necrosis Factor-Alpha (TNF-α) Leads to Downregulation of Nitrergic Neurons Following Bilateral Cavernous Nerve Injury and Modulates Penile Smooth Tone. (2021) (3)
- Immunosympathectomy for preservation of erectile function following cavernous nerve injury. (2015) (3)
- Evaluation and treatment of an unusual urachal mass: a case report (2015) (3)
- A retrospective analysis of the effect of time from diagnosis to cystectomy on survival in patients with muscle-invasive bladder cancer receiving neoadjuvant chemotherapy. (2015) (3)
- Long Term-Survival after Radical Prostatectomy for men with High Gleason Sum. (2010) (3)
- Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience. (2020) (3)
- Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes (2022) (3)
- BCG invokes superior STING‐mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer (2021) (3)
- Is intracavernous injection of papaverine a reliable screening test for vascular impotence? J. Buvat, M. Herbaut-Buvat, J.L. Dehaene, and A. Lemaire. (2009) (3)
- The Epidemiology and Pathophysiology of Erectile Dysfunction and the Role of Environment-Current Updates (2018) (3)
- Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non–muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial (2021) (3)
- Drug delivery options and therapeutic advances in the management of erectile dysfunction (2020) (3)
- 1041: Endothelial Nitric Oxide Synthase is a Homeostatic Regulator of RHOA/RHO-Kinase Activity in the Penis (2005) (3)
- Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons (2021) (3)
- Long-Term Survival after Radical Prostatectomy for men with High Gleason Sum in the Pathological Specimen (2010) (3)
- LBA6 FINAL RESULTS OF A PHASE 1 CLINICAL TRIAL EVALUATING THE USE OF A TISSUE ENGINEERED NEO-URINARY CONDUIT USING ADIPOSE DERIVED SMOOTH MUSCLE CELLS FOR URINARY RECONSTRUCTION (2018) (3)
- Is Prostate-Specific Antigen Surveillance Necessary in Men with Benign Prostate Pathology following Radical Cystoprostatectomy for Bladder Cancer? (2010) (3)
- Molecular subtyping reveals luminal bladder tumors have lower rates of pathological upstaging at radical cystectomy (2019) (3)
- MP89-09 STROMAL DERIVED FACTOR-1 TREATMENT AUGMENTS NERVE REGENERATION VIA CXCR4 ACTIVATION OF NEUROTROPHIC FACTORS IN THE MAJOR PELVIC GANGLION IN A DOSE-DEPENDENT FASHION (2016) (3)
- 1465 OUTCOMES OF MEN WITH AN ELEVATED PSA AS THEIR SOLE PREOPERATIVE INTERMEDIATE OR HIGH RISK FEATURE (2011) (3)
- 627P Phase II neoadjuvant trial of the anti–B7-H3 antibody, enoblituzumab, in men with localized prostate cancer: Safety, efficacy and immune correlates (2021) (2)
- In vivo Adenoviral Gene Transfer of CGRP and Related Peptides to the Rat and Mouse (2001) (2)
- Analysis of responses to angiotensin II in the mouse (2001) (2)
- PERIURETHRAL INJECTION OF HUMAN ADIPOSE TISSUE DERIVED STEM CELLS (HADSCS) PREVENTS FIBROSIS IN A NEW RAT MODEL OF URETHRAL STRICTURE (2015) (2)
- Race, ethnicity, and gender reporting in North American clinical trials for BCG-unresponsive non-muscle invasive bladder cancer (2021) (2)
- Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank (2016) (2)
- Episodic Hypertension With an Adrenal Mass: A Red Herring* (2014) (2)
- Cystoscopic management of an extruded coil from arteriovenous fistula embolization using arthroscopic instruments. (2008) (2)
- Evolving therapies for Peyronie’s disease: how can we work towards new drugs? (2020) (2)
- Port Site Recurrence Following a Robotic Laparoscopic Radical Nephroureterectomy for Sarcomatoid Variant of Urothelial Carcinoma (2017) (2)
- MP50-18 STUDY OF PSMA-TARGETED 18F-DCFPYL PET/CT IN THE EVALUATION OF MEN WITH AN ELEVATED PSA FOLLOWING RADICAL PROSTATECTOMY (2016) (2)
- Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor (2019) (2)
- Differential responses to ATPgammaS in the mesenteric and hindlimb vascular bed of the cat. (2001) (2)
- Adenocarcinoma of the Ileal Conduit in a Patient Born With Classic Bladder Exstrophy (2013) (2)
- Phase 2 trial of dovitinib in Bacillus Calmette-Guerin (BCG) refractory urothelial carcinoma (UC) with tumor FGFR3 mutations or over-expression: Hoosier Cancer Research Network GU12-157. (2016) (2)
- Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center study. (2022) (2)
- High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer (2017) (2)
- The Urogenital Epithelium and Corporal Tissues Are the Primary Targets of Rejection in Penile Vascularized Composite Allotransplantation: A New Real-Time Tissue-Based Monitoring System (2019) (2)
- A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study. (2023) (2)
- MP43-11 DEVELOPMENT OF A NANOSPHERE BASED DELIVERY OF SILDENAFIL TO SITES OF NERVE INJURY FOR PREVENTION OF POST-PROSTATECTOMY ERECTILE DYSFUNCTION USING A RAT MODEL OF CAVERNOUS NERVE INJURY (2014) (2)
- Abstract 4943: Engulfment gene GULP1 is a functional tumor suppressor through influencing TGF-β pathway and is silenced by promoter methylation in urothelial carcinoma (2015) (2)
- Urothelial Carcinoma (2012) (2)
- Safety and Efficacy of Reproductive organ-sparing radical cystectomy in women with variant histology and advanced stage (2021) (2)
- Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer (2020) (2)
- Combined next generation sequencing and flow cytometry analysis of an anti-PD-L1 partial responder over time: An exploration into mechanisms of PD-L1 activity and resistance (2017) (2)
- Management of Erectile Dysfunction Following Radical Prostatectomy (2001) (2)
- Transcriptome-wide analysis of Peyronie’s disease plaques using RNA sequencing uncovers targetable signalling pathways for medical therapy (2019) (2)
- Pedicled Antero-Lateral Thigh and Radial Forearm Free Flap Phalloplasty for Penile Reconstruction in Bladder Exstrophy Patients. (2020) (2)
- Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer (2022) (2)
- Plastic exposure and urological malignancies — an emerging field (2020) (2)
- THE FEASIBILITY OF EX VIVO EXPANDED MARROW STROMAL CELLS (STEM CELLS) GENETICALLY MODIFIED WITH ENOS FOR IMPROVING ERECTILE FUNCTION IN DIABETIC RATS (2006) (2)
- Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer (2020) (2)
- PDL1 status in muscle-invasive urothelial carcinoma in the context of neoadjuvant cisplatin-based chemotherapy. (2015) (1)
- 1040: Priapism in Sickle Cell Transgenic Mice is Associated with PDE5 Downregulation: Further Support for PDE5 Dysregulation in Priapism (2005) (1)
- Vasodilator Responses to ATP and UTP are cAMP Dependent in the Mesenteric Vascular Bed of the Cat (2001) (1)
- Abstract 1472: PDE5A Reciprocally Regulates NOS3 Expression and Activity in Vascular Endothelial Cells. (2006) (1)
- MP55-08 PATHOLOGIC RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN A MULTICENTRE COHORT OF PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER. (2014) (1)
- Frailty as a marker of adverse outcomes during cystectomy for urothelial cancer. (2015) (1)
- 488 Intratunical injection of autologous adipose stromal vascular fraction (SVF) prevents fibrosis in a rat model of Peyronie's disease (2014) (1)
- PD40-09 EVALUATING THE IMPACT OF LENGTH OF TIME FROM DIAGNOSIS TO SURGERY IN PATIENTS WITH UNFAVORABLE INTERMEDIATE TO VERY HIGH-RISK CLINICALLY LOCALIZED PROSTATE CANCER (2019) (1)
- Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer (2022) (1)
- Definitive therapy for men with newly-diagnosed oligometastatic prostate cancer: Initial surgical outcomes from a phase II study (2018) (1)
- MP47-20 INCREASED RHO-KINASE 2 AND AN INCREASE OF SYNTHETIC SMOOTH MUSCLE-SPECIFIC MARKER EXPRESSION IS OBSERVED IN THE CORPUS CAVERNOSUM OF PATIENTS WITH SEVERE ERECTILE DYSFUNCTION. (2014) (1)
- Abstract 3634: Endothelial cGMP-dependent Protein Kinase (PKG1) Directly Activates eNOS and Plays a Key Role in Modulation of Vascular Tone (2008) (1)
- Outcomes of inflatable penile prosthesis insertion using a neotunica allograft in neophalluses of patients on the bladder exstrophy-epispadias complex spectrum. (2020) (1)
- An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress? (2019) (1)
- Systematic Elucidation and Pharmacological Targeting of Tumor-Infiltrating Regulatory T Cell Master Regulators (2022) (1)
- Analysis of vasoconstrictor responses to histamine in the hindlimb vascular bed of the rabbit. (1999) (1)
- 469 GENITAL BLOOD FLOW AND BLADDER FUNCTION IN A FEMALE RAT MODEL FOR NERVE-SPARING HYSTERECTOMY (2011) (1)
- Galanin Is Upregulated In The Major Pelvic Ganglion In The Endogenous Neuroregenerative Response To Cavernous Nerve Injury (2012) (1)
- PD34-08 IMMUNE PROFILING OF TESTICULAR GERM CELL TUMORS REVEALS HIGH EXPRESSION OF PD-L1 AND PD-1 (2016) (1)
- MP60-12 MULTI-INSTITUTIONAL QUALITY CARE INITIATIVE TO IMPROVE THE CARE OF PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER (2014) (1)
- MP50-20 IMPLICATIONS OF DISCORDANT DIAGNOSTIC TO FINAL SURGICAL PATHOLOGY IN HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA (2019) (1)
- Sexual dysfunction: First EAU priapism treatment guidelines published (2014) (1)
- 289 ANATOMICAL EXTENT OF LYMPH NODE DISSECTION: IMPACT ON MEN WITH POSITIVE LYMPH NODES AT TIME OF RADICAL PROSTATECTOMY (2011) (1)
- INDUCTION OF PENILE ERECTION BY INTRACAVERNOSAL AND TRANSURETHRAL ADMINISTRATION OF ZAPRINAST AND PROSTAGLANDIN E1 (1999) (1)
- Surgical excision of a large, verrucous, scrotal mass in a patient with HSV-2 and HIV-1 co-infection (2018) (1)
- BLUE LIGHT CYSTOSCOPY FOR DIAGNOSIS OF UROTHELIAL BLADDER CANCER: RESULTS FROM A PROSPECTIVE MULTICENTER REGISTRY: MP15‐02 (2017) (1)
- Regenerative Medicine for Erectile Dysfunction Following Radical Prostatectomy: Are we Ready? (2016) (1)
- Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma (2015) (1)
- targeted 18 F-DCFPyL PET / CT in the Preoperative Staging of Men with High-risk Prostate Cancer : Results of a Prospective Phase II Single-Center Study (2017) (1)
- Cytotoxic T-lymphocytes and dendritic cells driving the inflammatory micro-environment of Peyronie’s disease (2020) (1)
- Multiple Intermediate-Risk Factors as a Prognostic Tool for Men With Localized Prostate Cancer (2014) (1)
- CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer (2018) (1)
- Systematic Review and Meta-Analysis of Response Rates in BCG-unresponsive Non–Muscle-Invasive Bladder Cancer: a Consensus Statement From the International Bladder Cancer Group (2022) (1)
- 1411: Rhoa/Rho-Kinase Suppresses Endothelial Nitric Oxide Synthase in the Penis: Novel Mechanism for Diabetic-Associated Erectile Dysfunction (2004) (1)
- MP46-06 SELECTION CRITERIA FOR EARLY BIOCHEMICAL RECURRENCE IN A HIGH-RISK RADICAL PROSTATECTOMY COHORT (2014) (1)
- Effect of chemotherapy and/or TURBT on pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer. (2016) (1)
- 1417: Mesenchymal Stem Cells Alone or Modified with ENOS Restore Erectile Function in the Aged Rat: Cell-Based Gene Therapy for Erectile Dysfunction (2004) (1)
- BASAL AND LUMINAL IMMUNOHISTOCHEMICAL PHENOTYPES IN MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMAS (MIBC) TREATED WITH NEOADJUVANT CHEMOTHERAPY (NAC): MP58‐05 (2017) (1)
- 80 ACTIVATED RHOA/RHO-KINASE LEADS TO IMPAIRED ERECTILE FUNCTION IN A CAVERNOUS NERVE INJURY RAT MODEL (2010) (1)
- ENHANCED RECOVERY AFTER RADICAL CYSTECTOMY REDUCES COST AND LENGTH OF STAY: THE JOHNS HOPKINS EXPERIENCE.: PD67‐11 (2017) (1)
- DENSE DOSE MVAC VERSUS GC IN PATIENTS WITH CT3‐4A BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A REAL WORLD EXPERIENCE: MP58‐04 (2017) (1)
- PATHOLOGIC UPSTAGING AT THE TIME OF RADICAL CYSTECTOMY IS ASSOCIATED WITH WORSE RECURRENCE FREE SURVIVAL IN PATIENTS WITH BCG-REFRACTORY BLADDER CANCER (2009) (1)
- In Reply (2019) (1)
- 42 Synergistic effects of the Rho kinase inhibitor Y-27632 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure (2015) (1)
- ' s Accepted Manuscript Human Penile Transplantation : An Emerging Therapy for Genitourinary Reconstruction (2017) (1)
- INCREASED COLLAGEN TYPE I AND III FIBERS IN THE PEYRONIE'S DISEASE RAT MODEL (1999) (1)
- MP49-06 ASSESSING CANCER PROGRESSION AND STABLE DISEASE AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER (2016) (1)
- PD36-06 EFFICACY OF ROLIPRAM LOADED NANOSPHERES IN LOCALIZED DELIVERY TO SITES OF NERVE INJURY FOR PREVENTION OF POST-PROSTATECTOMY ERECTILE DYSFUNCTION USING A RAT MODEL OF CAVERNOUS NERVE INJURY (2015) (1)
- Penis and scrotum transplantation: a paradigm for penile deficiency? (2018) (1)
- MP64-10 PERIOPERATIVE BLOOD TRANSFUSION IN BLADDER CANCER PATIENTS UNDERGOING RADICAL CYSTECTOMY IS ASSOCIATED WITH INCREASED MORBIDITY AND LENGTH OF STAY BUT NOT ADVERSE ONCOLOGIC OUTCOMES (2015) (1)
- Reducing preoperative blood orders and costs for radical prostatectomy. (2020) (1)
- Radical cystectomy in patients with preexisting three-piece inflatable penile prosthesis. (2013) (1)
- Analysis of responses to 5-hydroxytryptamine (serotonin) in the hindlimb vascular bed of the cat (1998) (1)
- 495 The neuroregenerative peptide Galanin is located in human nNOS-positive pelvic ganglia and cavernous nerves: A novel target for post-prostatectomy nerve regeneration? (2014) (1)
- MP29-17 CONTEMPORARY TRENDS IN READMISSION AND CARE FRAGMENTATION RATES FOLLOWING MAJOR UROLOGIC ONCOLOGY SURGERIES IN A NATIONALLY REPRESENTATIVE DATABASE (2019) (0)
- MP11-01 MECHANICAL PROPERTIES AND BICOMPATIBILITY OF ENGINEERED COLLAGEN SCAFFOLDS FOR RECONSTRUCTIVE UROLOGY (2019) (0)
- Editorial Commentary (2018) (0)
- UP.87: Bladder Cancer and the Aluminum Industry: A Review of the Current Literature (2008) (0)
- PS-04-004 Transcriptome-wide analysis of Peyronie's disease plaques using RNA sequencing uncovers targetable signaling pathways for medical therapy (2019) (0)
- PD09-02 ANTI-ADENOVIRAL ANTIBODY LEVELS PREDICT NADOFARAGENE FIRADENOVEC RESPONSE IN BCG-UNRESPONSIVE NMIBC: RESULTS FROM A PHASE 3 TRIAL (2021) (0)
- Kapitel 30 – Operationen bei Priapismus (2017) (0)
- MP19-18 INTRATUNICAL INJECTION OF ADIPOSE STROMAL VASCULAR FRACTION (SVF) PREVENTS FIBROSIS EXPRESSION IN A RAT MODEL OF PEYRONIE'S DISEASE (2015) (0)
- MP05-02 CTC AND CTDNA ASSAYS REVEAL COMPLIMENTARY INFORMATION FOR METASTATIC UROTHELIAL CANCER PATIENTS (2019) (0)
- MP47-12 TIME COURSE OF APOPTOTIC NEURONAL CELL DEATH IN THE MAJOR PELVIC GANGLION FOLLOWING CAVERNOUS NERVE INJURY (2014) (0)
- Erectile dysfunction and Peyronie’s disease (2019) (0)
- UROSEEK: A NOVEL NON‐INVASIVE MOLECULAR METHOD FOR EARLY DETECTION OF BLADDER CANCER: MP65‐13 (2018) (0)
- CAUSES, TIMING, AND HOSPITAL COSTS OF INDEX VS. NON‐INDEX HOSPITAL READMISSIONS FOLLOWING RADICAL PROSTATECTOMY: IMPLICATIONS FOR COST CONTAINMENT STRATEGIES: PD32‐08 (2017) (0)
- Penile sarcomatoid urothelial carcinoma: A case report (2021) (0)
- 120 CHOLINERGIC MEDIATED DETRUSOR DYSFUNCTION IN A FEMALE RAT MODEL OF PELVIC NEUROPRAXIA (2013) (0)
- Immunohistochemical expression and prognostic value of ARID1A in invasive urothelial carcinoma of urinary bladder (2016) (0)
- MP66-07 BCG INVOKES SUPERIOR STING-MEDIATED INNATE IMMUNE RESPONSE OVER RADIOTHERAPY IN A CARCINOGEN MURINE MODEL OF UROTHELIAL CANCER (2021) (0)
- Comparison of readmissions and hospital costs between continent and incontinent urinary diversion after radical cystectomy: An analysis of a nationally representative database (2018) (0)
- 386 Erectile Dysfunction in Peyronie's Disease is Independent of Cavernosal Inflammation and Fibrosis (2020) (0)
- Examining gemcitabine and docetaxel for recurrent NMIBC. (2017) (0)
- Contents Vol. 85, 2010 (2010) (0)
- Postoperative Management: Erectile Function (2014) (0)
- Bladder Cancer (2021) (0)
- Bladder Cancer: Epidemiology & Evaluation IIIPD57-02 CHARACTERIZATION OF UROTHELIAL CANCER CIRCULATING TUMOR CELLS WITH A NOVEL SELECTION-FREE METHOD (2017) (0)
- MP83-20 AN ASSESSMENT OF IMMUNE CHECKPOINT EXPRESSION AMONG PATIENTS WITH NMIBC UNDERGOING INTRAVESICAL BCG: IMPLICATIONS FOR ONGOING RANDOMIZED TRIALS. (2018) (0)
- 1876 A POST-CHEMOTHERAPY RESTAGING EVALUATION IMPROVES THE CORRELATION OF CLINICAL AND PATHOLOGICAL STAGE IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR BLADDER CANCER (2013) (0)
- PD33-07 PARTIAL VS. COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER PATIENTS: A COMPARISON OF POST-CYSTECTOMY OUTCOMES (2016) (0)
- STEM CELL ACTIVATION IN THE MAJOR PELVIC GANGLION IS ENHANCED BY STROMAL DERIVED FACTOR‐1 PENILE INJECTIONS FOLLOWING NERVE INJURY: MP41‐15 (2017) (0)
- HP-07-003 Ex-vivo mixed lymphocyte reaction model of human corporal tissue can be used to assess the effects of rejection on erectile function in the setting of penile transplantation (2016) (0)
- 119 PERIOPERATIVE BETAMETHASONE COUNTERACTS BLADDER DYSFUNCTION IN VIVO IN A RAT MODEL FOR NERVE-SPARING HYSTERECTOMY (2012) (0)
- THREE‐DIMENSIONAL ORGANOID CULTURE REVEALS INVOLVEMENT OF WNT/&bgr;‐CATENIN PATHWAY IN PROLIFERATION OF BLADDER CANCER CELLS: MP54‐06 (2018) (0)
- Analysis of responses to histamine in the systemic and hindquarters vascular bed of the rabbit (1998) (0)
- Treatment with a New Nitric Oxide Donor, a Hybrid Derived from Thalidomide and Hydroxycarbamide 3-(1,3-dioxoisoindolin-2-yl)Benzyl Nitrate, Reverses Priapism in the Sickle Cell Mouse and the Nitric Oxide-Deficient Mouse (2016) (0)
- Overexpression of IGF1R predicts outcome in invasive urothelial carcinoma of urinary bladder (2016) (0)
- Blue light cystoscopy for diagnosis of urothelial bladder cancer: Results from a multicenter registry (2018) (0)
- MP50-09 BLADDER RECURRENCE IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (2019) (0)
- MP-2.09: Detection of Circulating Tumor Cells in the Blood of Patients with Muscle Invasive Bladder Cancer Prior to Radical Cystectomy (2008) (0)
- PD20-12 COMPARING PROVIDER-REPORTED SEXUAL HEALTH COUNSELING OF MALE AND FEMALE RADICAL CYSTECTOMY PATIENTS (2019) (0)
- Stem and endothelial progenitor cells in erectile biology: future therapeutic applications and potential biomarker for erectile dysfunction (2008) (0)
- MP73-11 ROLE OF BLUE LIGHT CYSTOSCOPY IN DETECTING INVASIVE BLADDER TUMOR: DATA FROM MULTI-INSTITUTIONAL REGISTRY (2020) (0)
- EFFECT OF BILATERAL CAVERNOUS NERVE INJURY ON NITRIC OXIDE AND RHO-KINASE SIGNALING IN A RAT MODEL OF POST- RADICAL PROSTATECTOMY ERECTILE DYSFUNCTION (2008) (0)
- MP59-01 PEYRONIE'S DISEASE PLAQUE TRANSCRIPTOME-WIDE ANALYSIS USING RNA SEQUENCING REVEALS TARGETABLE SIGNALLING PATHWAYS FOR MEDICAL TREATMENT (2019) (0)
- MP48-16 EMPIRICAL VS. RISK-BASED APPROACH TO INTRACAVERNOSAL INJECTION THERAPY: A PROSPECTIVE STUDY (2014) (0)
- INTRAVESICAL BCG INDUCES CD4+ T CELL EXPANSION BUT NOT ACTIVATION IN A CLINICALLY RELEVANT IMMUNE COMPETENT MODEL OF BLADDER CANCER: MP65‐06 (2017) (0)
- Generation of Vasoactive Prostanoids by the Cyclooxygenase‐2 Pathway in the Cardiovascular System of the Rat (2004) (0)
- PD36-04 TNF-α INHIBITS NEURITE OUTGROWTH FROM THE MAJOR PELVIC GANGLION BY INDUCING M1/M2 MACROPHAGES EX VIVO. (2015) (0)
- Presentation and management of a patient with subcutaneous metastatic transitional cell carcinoma of the bladder (2008) (0)
- Reply by Authors. (2019) (0)
- 811 CAVERNOUS NERVE INJURY INCREASES STORE OPERATED CALCIUM CHANNELS AND APOPTOTIC MARKERS IN THE MAJOR PELVIC GANGLION (2012) (0)
- Abstract 3511: Varying Treatment outcomes of small molecule STING Agonist ADU-S100 in intratumoral and intravesical treatment regimens in syngeneic murine MB49 and in the N-methyl-N-nitrosourea (MNU) rat Model of urothelial carcinoma (2022) (0)
- Chronic Phosphodiesterase Type 5 Inhibitor Therapy Reduces Priapic Activity in Transgenic Sickle Cell Mice: Restoring Nitric Oxide/Redox Balance in the Penis. (2009) (0)
- HP-07-001 Exogenous TNF-alpha induces apoptosis of nitrergic neurons and impairs neurite outgrowth from the major pelvic ganglion (2016) (0)
- 311 Non-alcoholic Fatty Liver Disease and Erectile Dysfunction in S-nitrosoglutathione Reductase (GSNOR) Deficiency (2020) (0)
- 805 THE MATRICELLULAR PROTEIN HEVIN IS INCREASED IN THE MAJOR PELVIC GANGLION FOLLOWING CAVERNOUS NERVE INJURY AND INHIBITS NEURITE OUTGROWTH (2012) (0)
- Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer (2022) (0)
- 564 OUTCOMES OF COMBINED INFLATABLE PENILE PROSTHESIS-ARTIFICIAL URINARY SPHINCTER VS. INDIVIDUAL DEVICE INSERTION-A RETROSPECTIVE SINGLE INSTITUTION STUDY (2013) (0)
- Abstract 558: Mutational heterogeneity related to neoadjuvant therapy response in muscle invasive urothelial cell carcinoma revealed by whole-exome sequencing (2014) (0)
- MP13-03 FEMALE ORGAN SPARING AT THE TIME OF CYSTECTOMY (2021) (0)
- MP52-05 BILATERAL CAVERNOUS NERVE INJURY INDUCES TEMPORAL INCREASE OF TNF-α AND RECRUITMENT OF MACROPHAGES IN THE MAJOR PELVIC GANGLION IN VIVO. (2015) (0)
- PD-L1 and PD-1 expression patterns in patients with NMIBC undergoing intravesical BCG (2017) (0)
- Increased Level of Tumor Necrosis Factor-Alpha (TNF-α) Leads to Downregulation of Nitrergic Neurons Following Bilateral Cavernous Nerve Injury and Modulates Penile Smooth Tone. (2021) (0)
- HOSPITALIZATION AND READMISSION COSTS AFTER RADICAL CYSTECTOMY IN A NATIONALLY REPRESENTATIVE SAMPLE: NEOBLADDER VS. ILEAL CONDUIT: MP54‐04 (2017) (0)
- 067 Rapamycin Suppresses NADPH Oxidase-mediated Reactive Oxygen Species Production and Reverses Erectile Dysfunction in Western Diet-fed Mice (2019) (0)
- STROMAL DERIVED FACTOR‐1 TREATMENT ACTIVATES STEM CELLS AND INCREASES NEURONAL TISSUE EXPRESSION OF NEUROTROPHINS: PD49‐09 (2018) (0)
- Subject Index Vol. 85, 2010 (2010) (0)
- 327 Time-dependent changes in the regulation of neurotrophin expression and neurite sprouting in the rat major pelvic ganglion following cavernous nerve injury (2013) (0)
- New therapies for treating hypertension: what every physician should know. (2000) (0)
- Phase 1 clinical trial to evaluate the use of a tissue engineered neo-urinary conduit using adipose derived smooth muscle cells after radical cystectomy (2019) (0)
- PD51-03 DIGITAL PATHOLOGY OF CIRCULATING TUMOR CELLS WITH MORPHOLOGIC ANALYSIS IS FEASIBLE IN LOCALIZED BLADDER CANCER (2020) (0)
- Abstract 5523: Contribution of Ox-LDL Induced Arginase Activation to Vascular Dysfunction in Cigarette Smoke (2009) (0)
- 059 Cysteine 42 of Protein Kinase G 1? is Critical for Erection Generation (2017) (0)
- Residual CIS after neoadjuvant chemotherapy and radical cystectomy for muscle invasive bladder cancer: Implications for neoadjuvant trials. (2022) (0)
- Running Foot: 18 F-DCFBC Imaging of Primary Prostate Cancer (2015) (0)
- 073 Neurotoxic M1 Macrophages are Recruited to the Major Pelvic Ganglion by Increased TNF-alpha Following Bilateral Cavernous Nerve Injury (2016) (0)
- Renal cell carcinoma presenting with brain metastasis from a 1.6 cm primary tumor. (2013) (0)
- NO Effect on Penile Blood Flow and Lower Genitourinary Tract Function (2000) (0)
- MP56-08 CLINICOPATHOLOGIC AND SURVIVAL AFTER CYSTECTOMY OUTCOMES IN SQUAMOUS CELL CARCINOMA OF THE BLADDER (2022) (0)
- MP82-06 NEW CLASSIFICATION FOR UPPER TRACT UROTHELIAL CARCINOMA TO ENHANCE RISK STRATIFICATION OF PATIENTS ELIGIBLE TO ENDOSCOPIC MANAGEMENT: AN INTERNATIONAL COLLABORATIVE STUDY (2020) (0)
- Urinary Diversion and Perioperative Care Re : (2016) (0)
- 018 TNF-alpha Inhibition Improves Parasympathetic Nerve Function and is Associated with Altered Macrophage Infiltration of the Major Pelvic Ganglion following Nerve Injury (2018) (0)
- A COMPARISON OF POST‐CYSTECTOMY RECURRENCE AND SURVIVAL IN NAC‐RESPONSIVE MIBC VS. HIGH‐RISK NMIBC PATIENTS: SIMILAR PATHOLOGIC STAGE YET DIFFERENT OUTCOMES: PD57‐12 (2017) (0)
- 962: Periurethral injection of human adipose tissue derived stem cells prevents fibrosis and counteracts bladder dysfunction in a rat model of iatrogenic urethral stricture (2015) (0)
- 326 Galanin, a trophic neuropeptide, is upregulated in the rat major pelvic ganglia following cavernous nerve crush injury (2013) (0)
- impairment in nitric oxide bioavailability Hemolysis in sickle cell mice causes pulmonary hypertension due to global (2012) (0)
- 889 EFFECT OF EXERCISE ON ERECTILE FUNCTION AFTER BILATERAL NERVE CRUSH INJURY IN A RAT MODEL (2010) (0)
- 015 Degeneration of Parasympathetic Nerve Can be Prevented by Inhibitin TNF-Alpha Signaling (2017) (0)
- MP65-09 NEOADJUVANT CHEMOTHERAPY AND PREDICTORS OF LONG-TERM CANCER-SPECIFIC SURVIVAL (2014) (0)
- MP26-15 MOLECULAR SUBTYPING REVEALS LUMINAL BLADDER TUMORS HAVE LOWER RATES OF PATHOLOGICAL UPSTAGING AT RADICAL CYSTECTOMY (2019) (0)
- 191 Comparing Provider-Led Sexual Health Counseling of Male and Female Radical Cystectomy Patients (2020) (0)
- Urethral carcinosarcoma from bladder carcinosarcomatous lesions: analysis of clinicopathological features. (2009) (0)
- Intratumoral infiltration of CD8+/Ki-67+ lymphocytes is stronger in higher grade penile squamous cell carcinomas (2018) (0)
- 324 Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease (2013) (0)
- Differences in provider-led sexual health counseling practices for male versus female radical cystectomy patients (2019) (0)
- TEMPORAL CHANGES IN NEUROTROPHIC FACTORS AND NEURITE GROWTH FOLLOWING CAVERNOUS NERVE INJURY (2012) (0)
- MP89-16 INCREASE IN TNF-ALPHA LEADS TO APOPTOSIS OF NITRERGIC NEURONS IN MAJOR PELVIC GANGLION AFTER BILATERAL CAVERNOUS NERVE INJURY (2016) (0)
- MP09-15 VALIDATION OF EX-VIVO MURINE BLADDER MODEL TO TEST RHOGDI-BASED BLADDER GENE THERAPIES FOR BENIGN AND MALIGNANT BLADDER PATHOLOGIES (2018) (0)
- 737 The interval between diagnosis and radical cystectomy does not impact the outcomes of patients treated with neoadjuvant chemotherapy (2015) (0)
- ANDROGEN SUPPLEMENTATION IMPROVES RIGHT VENTRICULAR SYSTOLIC FUNCTION IN A CHRONIC HYPOXIA MODEL (2012) (0)
- CHARACTERIZATION OF NEURONAL CELL DEATH IN THE MAJOR PELVIC GANGLION FOLLOWING CAVERNOUS NERVE INJURY (2014) (0)
- 023 Pelvic Nerve Injury Leads to Increased Rho-Kinase Mediated Adrenergic Vasoconstriction of the Distal Vagina (2016) (0)
- PS-04-003 SDF-1 treatment promotes major pelvic ganglion neurite outgrowth by upregulating neurotrophic factor expression, which is blocked by AMD3100 (2016) (0)
- Author Reply. (2017) (0)
- PS-04-006 Osteopontin is a novel player in endogenous neuroregeneration after BCNI (2016) (0)
- 126 Prognostic model for predicting survival in patients with disease recurrence following radical cystectomy (2014) (0)
- 013 Molded Collagen Scaffolds as an Engineered Replacement for Biological-sourced Materials in Reconstructive Urological Applications (2017) (0)
- MP41-11 DEVIATIONS IN CYCLES OF NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER AND IMPLICATIONS FOR PATHOLOGIC RESPONSE AND SURVIVAL (2021) (0)
- MP33-18 CYTOTOXIC T-LYMPHOCYTES AND DENDRITIC CELLS MAINTAINING THE INFLAMMATORY MICRO-ENVIRONMENT OF PEYRONIE'S DISEASE (2020) (0)
- 003 Novel Model of Ex-Vivo Mixed Lymphocyte Reaction to Assess the Effects of Rejection on Erectile Function in the Setting of Human Penile Transplantation (2016) (0)
- GALANIN IS UPREGULATED IN THE RAT MAJOR PELVIC GANGLION FOLLOWING CAVERNOUS NERVE INJURY: A NOVEL TARGET IN ERECTILE FUNCTION RECOVERY FOLLOWING RADICAL PROSTATECTOMY? (2012) (0)
- Report of Primary Recurrent Malignant Melanoma of the Urinary Bladder q (2013) (0)
- Role of arginase in the pulmonary vascular response to chronic hypoxia in the mouse: Augmentation of responses by in vivo gene transfer (2003) (0)
- 885 Osteopontin is an important player in endogenous neuroregeneration after cavernous nerve injury (2016) (0)
- 1645: Feline Penile Erection Induced by Topical Glans Penis Application of Combination Alprostadil and Sepa (Topiglan) (2004) (0)
- 053 Inhibition of TNF-alpha Signaling can Prevent Parasympathetic Nerve Function by Upregulating ERK Signaling (2017) (0)
- 694 PROSTATIC BUDDING IN DEVELOPMENT IS MEDIATED BY A RHOA / ROCK DEPENDENT PATHWAY (2010) (0)
- Spotlight on Sexual Medicine: Advances and Issues of Debate. (2019) (0)
- MP86-07 CONTRIBUTIONS OF READMISSIONS TO 90-DAY EPISODE COSTS FOLLOWING MAJOR UROLOGIC ONCOLOGY SURGERIES: WHICH SURGERIES SHOULD BE TARGETED FOR IMPROVEMENT? (2018) (0)
- Multi-Institution Evaluation of Sequential Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guerin Naïve Patients with Non-Muscle Invasive Bladder Cancer (2022) (0)
- MP18-02 EFFICACY OF PREOPERATIVE CHEMOTHERAPY ON OUTCOMES OF HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA (UTUC) (2018) (0)
- MP55-18 SARCOMATOID UROTHELIAL CARCINOMA: CLINICO-PATHOLOGICAL ANALYSIS OF 93 CASES WITH EMPHASIS ON PT1 OUTCOMES IN PATIENTS WHO UNDERWENT EARLY CYSTECTOMY AND/OR NEOADJUVANT CHEMOTHERAPY (2020) (0)
- EFFECT OF BONE MARROW TRANSPLANTED SICKLE HEMOGLOBIN AND HEMOLYSIS ON THE DEVELOPMENT OF PRIAPISM IN A NEW ANIMAL MODEL OF SICKLE CELL ANEMIA-ASSOCIATED PRIAPISM (2009) (0)
- Analysis of Vasodepressor Responses to Nociceptin and Nociceptin Analogs in the Systemic Vascular Bed of the Anesthetized Rabbit In Vivo (1998) (0)
- Reply to C.G. Rusthoven et al. (2015) (0)
- Editorial Comment. (2018) (0)
- 185 Impact of RhoGDI Gene Transfection of Bladder Smooth Muscle Contractility in a Validated Ex-vivo Murine Model (2019) (0)
- Commentary on Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease. Guzzo TJ (2009) (0)
- Human adipose derived stem cells (HADSCS) prevents fibrosis and bladder dysfunction in a rat model of urethral stricture (2015) (0)
- PD15-12 BLADDER CANCER CIRCULATING TUMOR CELL CONCENTRATION FLUCTUATES IN THE ABSENCE OF SYSTEMIC THERAPY OR SURGERY (2018) (0)
- Sexual health outcomes after penile reconstruction in the exstrophy-epispadias complex. (2022) (0)
- MP89-17 NEUROTOXIC M1 MACROPHAGES ARE PREDOMINANTLY RECRUITED TO MAJOR PELVIC GANGLION FOLLOWING BILATERAL CAVERNOUS NERVE INJURY, LEADING TO IMPAIRED PARASYMPATHETIC-MEDIATED RELAXATION OF CORPUS CAVERNOSUM (2016) (0)
- CHARACTERIZATION OF UROTHELIAL CANCER CIRCULATING TUMOR CELLS WITH A NOVEL SELECTION‐FREE METHOD: PD57‐02 (2017) (0)
- Abstract 1363: Epigenetic inactivation of VGF in urothelial cell carcinoma and its potential as a non-invasive biomarker using urine (2014) (0)
- MP38-18 SELF-REPORTED QUALITY OF LIFE AS A PREDICTOR OF MORTALITY IN BLADDER AND UPPER TRACT MALIGNANCIES (2021) (0)
- Increased in Tumor Necrosis Factor-Alpha (TNFA) leads to downregulation of nitrergic neurons after cavernous nerve injury and impairs penile smooth tone (2020) (0)
- PD60-05 NEOADJUVANT CHEMOTHERAPY PLUS RADICAL CYSTECTOMY VERSUS RADICAL CYSTECTOMY ALONE IN CLINICAL T2 BLADDER CANCER PATIENTS WITHOUT HYDRONEPHROSIS (2020) (0)
- 061 Stromal Derived Factor-1 Penile Injections Improve Erectile Function Preservation following Nerve Crush Injury by Enhancing Stem Cell Recruitment to the Major Pelvic Ganglion (2017) (0)
- Histopathologic and clinical comparison of recurrent and non-recurrent urethral stricture disease treated by reconstructive surgery (2021) (0)
- A phase 1, open-label trial to evaluate feasibility and safety of intramural injection of belzupacap sarotalocan (AU-011) in non-muscle–invasive bladder cancer (NMIBC). (2023) (0)
- MP19-16 HUMAN ADIPOSE TISSUE DERIVED STEM CELLS (HADSCS) PREVENTS FIBROSIS AND BLADDER DYSFUNCTION IN A RAT MODEL OF URETHRAL STRICTURE (2015) (0)
- Abstract 1592: Bladder cancer circulating tumor cell concentration fluctuates in the absence of systemic therapy or surgery (2018) (0)
- Intratunical injection of adipose stromal vascular fraction (SVF) prevents fibrosis expression in a rat model of Peyronie’s disease (2015) (0)
- MOLECULAR SUBTYPE CLASSIFICATION OF N‐METHYL‐N‐NITROSOUREA‐INDUCED UROTHELIAL CANCERS AND EX‐VIVO CULTURED SPHEROIDS IN RATS.: MP48‐19 (2017) (0)
- 1669 PENILE STRAIGHTENING MANEUVERS EMPLOYED DURING INFLATABLE PENILE PROSTHESIS INSERTION: SURGICAL OPTIONS AND OUTCOMES (2013) (0)
- Non-invasive detection of bladder cancer through the analysis of driver gene 1 mutations and aneuploidy 2 3 (2017) (0)
- Reply by Authors. (2021) (0)
- MP38-16 JUSTIFICATION OF 8TH EDITION AJCC TUMOR NODE METASTASIS UPDATES FOR BLADDER CANCER STAGING (2019) (0)
- MP69-12 PREDICTORS OF SURGICAL CURE IN MEN WITH VERY HIGH RISK PROSTATE CANCER (2016) (0)
- MP67-10 INCREASED INFECTIOUS COMPLICATIONS IN TRANSFUSED PATIENTS AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER (2015) (0)
- PD36-02 INCREASED VASCULAR REMODELING AND CALCIFICATION OF CORONARY AND INTERNAL PUDENDAL ARTERIES FROM MEN WITH CARDIOVASCULAR DISEASE (2015) (0)
- Feasibility of digital pathology of circulating tumor cells with morphologic analysis in localized bladder cancer. (2020) (0)
- MOLECULAR CHARACTERIZATION OF N‐METHYL‐N‐NITROSOUREA‐INDUCED BLADDER UROTHELIAL TUMOR IN RATS: MP54‐12 (2018) (0)
- MP09-11 TRENDS IN SURGICAL MANAGEMENT OF HIGH-RISK PROSTATE CANCER: EVIDENCE OF AN EVOLVING TREATMENT PARADIGM (2016) (0)
- Positive LymphNodes at Radical Prostatectomy : The JohnsHopkinsHospital 30-Year Experience (2013) (0)
- Preliminary evaluation of 18F-DCFBC PSMA PET for detection of primary prostate cancer (2013) (0)
- MP28-10 IGF1R IMMUNOEXPRESSION IN SUPERFICIAL NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF URINARY BLADDER (2014) (0)
- MP23-12 INTRAOPERATIVE RADIATION THERAPY DURING GENITOURINARY SURGERY: THE IMPORTANCE OF SPECIMEN MARGIN STATUS IN IMPROVING SURVIVAL (2016) (0)
- 028 TNF-alpha inhibition can prevent smooth-muslce dysfunction following bilateral cavernous nerve injury by upregulating GFAP expression through activation of ERK1/ERK2 signaling (2018) (0)
- 40 Neurite outgrowth of pelvic neurons is stimulated by the neurotrophic peptide galanin (2015) (0)
- OP1-04 IDENTIFICATION AND VALIDATION OF PROTEIN BIOMARKERS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN MUSCLE INVASIVE UROTHELIAL CARCINOMA (2014) (0)
- MP27-15 TUMOR LOCATION AS A PREDICTOR OF SURVIVAL FOLLOWING NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CANCER: A U.S. POPULATION BASED ANALYSIS (2004-2012) (2016) (0)
- 820 TEMPORAL CHANGES IN NEUROTROPHIC FACTORS AND NEURITE GROWTH FOLLOWING CAVERNOUS NERVE INJURY (2013) (0)
- 083 Intracavernosal Injections of Stromal Derived Factor-1 (SDF1) Prevents Erectile Dysfunction in Nerve Injury Model by Increasing Stem Cell Upregulation in the Penis (2021) (0)
- MP14-20 SITE OF METASTATIC RECURRENCE IMPACTS PROGNOSIS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (2020) (0)
- MP22-14 DEFINITIVE THERAPY FOR MEN WITH NEWLY-DIAGNOSED OLIGOMETASTATIC PROSTATE CANCER: INITIAL SURGICAL OUTCOMES FROM A PHASE II STUDY (2018) (0)
- 074 S-Nitrosoglutathione Reductase (GSNOR) Protects against Western Diet Induced Reactive Oxygen Species Production and Erectile Dysfunction (2016) (0)
- Association of IGF1R overexpression (OE) with outcome in invasive urothelial carcinoma (UC) of urinary bladder. (2013) (0)
- SILDENAFIL CITRATE INHIBITS SUPEROXIDE FORMATION AND RESTORES ENDOTHELIAL FUNCTION IN A MOUSE MODEL OF SECOND-HAND SMOKE INDUCED ERECTILE DYSFUNCTION (2008) (0)
- Re: Radical cystectomy in patients with preexisting three-piece inflatable penile prosthesis (2013) (0)
- POTENTIAL ROLE FOR NESTIN, A NEURAL STEM CELL MARKER, IN THE PATHOPHYSIOLOGY OF INJURY AND REPAIR OF THE CAVERNOUS NERVE (2009) (0)
- 815 Validation of prognostic value of Bajorin criteria for cancer-specific survival in patients who have disease recurrence after radical cystectomy for urothelial carcinoma of the bladder (2013) (0)
- COMPARISON OF INITIAL AND FOLLOW‐UP HOSPITAL COSTS FOR MINIMALLY INVASIVE VS. OPEN RADICAL CYSTECTOMY IN A NATIONALLY REPRESENTATIVE SAMPLE: PD14‐12 (2017) (0)
- 1354 PRE-OPERATIVE PREDICTORS OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2013) (0)
- INTRATUNICAL INJECTION OF ADIPOSE STROMAL VASCULAR FRACTION PREVENTS FIBROSIS IN A RAT MODEL OF PEYRONIE'S DISEASE (2014) (0)
- 955: Serum Biomarkers of Endothelial Function and Oxidative Stress after Daily Dosing of Sildenafil in Type 2 Diabetic Men with Erectile Dysfunction (2007) (0)
- MP65-19 ERECTILE DYSFUNCTION IN PEYRONIE’S DISEASE IS INDEPENDENT OF CAVERNOSAL INFLAMMATION AND FIBROSIS (2019) (0)
- PD47-07 A GENETICALLY MODIFIED BCG THAT OVEREXPRESSES A STING AGONIST SHOWS ENHANCED ANTITUMOR EFFICACY MEDIATED BY AN M1 MACROPHAGE POLARIZATION WITH POTENTIATION OF TRAINED IMMUNITY (2020) (0)
- DOES SURGICAL APPROACH AFFECT RATES OF ERECTILE DYSFUNCTION TREATMENT FOLLOWING RADICAL CYSTECTOMY: ANALYSIS OF A NATIONWIDE INSURANCE CLAIMS DATABASE: PD69‐10 (2017) (0)
- Title: 18 F-DCFBC PET/CT for PSMA-based Detection and Characterization of Primary Prostate Cancer F-DCFBC Imaging of Primary Prostate Cancer (2015) (0)
- Preclincial Evaluation of Intravesical Cisplatin Nanoparticles for Non–Muscle-Invasive Bladder Cancer (2017) (0)
- Major pelvic ganglion neurons express CXCR4, which binds stromal derived factor-1 and enhances neurotrophin protein levels and neurogenesis (2018) (0)
- MP08-17 BLUE LIGHT CYSTOSCOPY IMPROVES DETECTION RATES FOR UROTHELIAL BLADDER CANCER COMPARED TO WHITE LIGHT CYSTOSCOPY: UPDATED RESULTS FROM A PROSPECTIVE MULTICENTER REGISTRY (2018) (0)
- MP58-11 NIGHTLY SILDENAFIL USE AFTER RADICAL PROSTATECTOMY HAS ADVERSE EFFECTS ON URINARY CONVALESCENCE: RESULTS FROM A RANDOMIZED TRIAL OF NIGHTLY VS ON-DEMAND DOSING REGIMENS (2014) (0)
- MP43-10 CAVERNOUS NERVE INJURY INDUCED TEMPORAL INCREASE IN NEUROINFLAMMATION AND CYTOKINE INDUCTION IN THE MAJOR PELVIC GANGLION OF THE RAT (2014) (0)
- 016 Ex-Vivo Model of Human Penile Transplantation and Rejection: Effects of Rejection and Immunosuppresion on Erectile Physiology (2017) (0)
- 021 SDF-1 Treatment Promotes Neurite Outgrowth from the Major Pelvic Ganglion by Upregulating Neurotrophins (2016) (0)
- 487 Intratunical injection of human adipose tissue–derived stem cells partially reverts fibrosis and restores collagen III/I ratio in a rat model of chronic Peyronie's disease (2014) (0)
- 1423: PDE5 Dysregulation in Penile Erectile Tissue: Mechanism of Priapism (2004) (0)
- 019 Galanin mediates endogenous nitrinergic nerve outgrowth in vitro and partially restores erectile function after cavernous nerve injury in vivo (2018) (0)
- 532 Final pathologic stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer: Does pT0 predict better survival than pTa/pTis/pT1? (2015) (0)
- Excessive Thiol Nitrosylation Predisposes to Western Diet‐Induced Redox Imbalance and Erectile Dysfunction (2017) (0)
- 2027 NERVE-SPARING QUALITY IS ASSOCIATED WITH RECOVERY OF URINARY CONTINENCE AFTER LAPAROSCOPIC RADICAL PROSTATECTOMY (2010) (0)
- 675: Phosphodiesterase Type 5 Inhibitor Therapy Corrects “Nitric Oxide” Imbalance in Sickle Cell Anemia-Associated Priapism (2007) (0)
- 1116 GENITAL BLOODFLOW AND BLADDER FUNCTION IN A FEMALE RAT MODEL FOR NERVE-SPARING HYSTERECTOMY (2011) (0)
- Remarkable difference between 3D and 2D cultures of bladder cancer cells in response to drugs: A concrete example for importance of 3D culture (2019) (0)
- MP84-18 NON-ALCOHOLIC FATTY LIVER DISEASE AND ERECTILE DYSFUNCTION IN S-NITROSOGLUTATHIONE REDUCTASE (GSNOR) DEFICIENCY (2020) (0)
- MP63-05 LONGER DURATION BLOOD STORAGE IS LINKED TO INFECTION AND MORBIDITY IN RADICAL CYSTECTOMY PATIENTS WHO RECEIVE BLOOD TRANSFUSION (2016) (0)
- Is Blue Light the Next Little Blue Pill?: Effects of Light‐Stimulation on Erectile Dynamics (2020) (0)
- Comparative responses to alpha,beta-methylene-ATP in cat pulmonary, mesenteric, and hindquarter vascular beds. (2002) (0)
- A GENOMIC CLASSIFIER FOR IDENTIFYING A NEUROENDOCRINE‐LIKE BLADDER CANCER SUBTYPE: MP58‐19 (2018) (0)
- MP67-12 THE MODIFIED FRAILTY INDEX AS A MARKER OF ADVERSE OUTCOMES DURING CYSTECTOMY FOR UROTHELIAL CANCER (2015) (0)
- MP61-03 PATHOLOGIC LYMPH NODE METASTASIS FOLLOWING NEOADJUVANT CHEMOTHERAPY AND STRATIFICATION OF RISK GROUPS (2014) (0)
- PD42-01 RESIDUAL MUSCLE-INVASIVE DISEASE AT CYSTECTOMY IS NOT ACCURATELY PREDICTED BY POST-CHEMOTHERAPY RESTAGING PROTOCOLS INCLUDING DNA DAMAGE RESPONSE GENE MUTATION ANALYSIS (2020) (0)
- PD8-08 A PORCINE MODEL OF TOTAL CYSTECTOMY AND URINARY REPLACEMENT BY TISSUE ENGINEERED URINARY DIVERSION USING A BIODEGRADABLE TUBULAR SCAFFOLD SEEDED WITH AUTOLOGOUS SMOOTH MUSCLE CELLS (2014) (0)
- MP28-08 DPC4 LOSS OF EXPRESSION IN INVASIVE UROTHELIAL CARCINOMAS: AN IMMUNOHISTOCHEMICAL STUDY (2014) (0)
- 650 A multi-institutional analysis of pathological and survival outcomes in patients with clinically node positive urothelial bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy (2015) (0)
- PD58-11 PREVENTION OF SURGICAL SITE INFECTIONS WITH PROPHYLACTIC INCISIONAL NEGATIVE PRESSURE WOUND THERAPY IN A RADICAL CYSTECTOMY ERAS PROTOCOL (2019) (0)
- 887 SDF-1 treatment facilitates axonal regeneration from the major pelvic ganglion in a dose-dependent fashion (2016) (0)
- MP18-01 INCIDENCE OF LOWER PATHOLOGIC STAGE IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA (2018) (0)
- In vivo gene transfer of enos and sod reduces superoxide formation in angiotensin II-treated mice (2002) (0)
- Abstract 3253: Next-gen STING-agonist like BCG confers enhanced immunogenicity and antitumor efficacy in vitro and in vivo (2019) (0)
- MP57-02 “NEXT-GEN STING-AGONIST LIKE BCG CONFERS ENHANCED IMMUNOGENICITY AND ANTITUMOR EFFICACY IN VITRO AND IN VIVO” (2019) (0)
- 1868 PROGNOSTIC VALUE OF BAJORIN CRITERIA FOR CANCER-SPECIFIC SURVIVAL IN PATIENTS WHO HAVE DISEASE RECURRENCE AFTER RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER (2013) (0)
- 1629 IMPACT OF SURGICAL VOLUME ON PERIOPERATIVE OUTCOMES AND COSTS OF RADICAL CYSTECTOMY: ANALYSIS OF THE MARYLAND HEALTH SERVICES COST REVIEW COMMISSION DATABASE (2013) (0)
- Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer patients without hydronephrosis: results from a large multicenter cohort study (2020) (0)
- Vascular effects to ATPγS are bed dependent in the cat (1998) (0)
- Metabolomics and urologic oncology. (2011) (0)
- Clinical Management (2022) (0)
- MP19-04 QUALITY OF LIFE AFTER A UROLOGIC CANCER DIAGNOSIS (2021) (0)
- 735 Nomogram predicting cancer specific mortality (CSM) after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer (BC): Results of an international consortium (2015) (0)
- A genomic classifier for identifying a neuroendocrine-like bladder cancer subtype. (2018) (0)
- 323 Stromal derived factor-1 treatment results in stem cell pathway activation in penile tissues and increased neurotrophins in major pelvic ganglion (2018) (0)
- PUTATIVE MECHANISMS OF SILDENAFIL'S PREVENTION OF PRIAPISM IN TRANSGENIC SICKLE CELL MICE: ROLE OF eNOS UNCOUPLING AND PHOSPHORYLATION (2008) (0)
- Urological Survey Trauma , and Genital and Urethral Reconstruction Re : Preoperative Hair Removal on the Male Genitalia : Clippers vs . (2013) (0)
- Practice Patterns Regarding Female Reproductive Organ-Sparing and Nerve-Sparing Radical Cystectomy Among Urologic Oncologists in the United States. (2023) (0)
- Erratum: Feline penile erections induced by topical glans penis application of combination alprostadil and SEPA (Topiglan) International Journal of Impotence Research (2004) 16, (303) (doi: 10.1038/sj.ijir.3901229)) (2004) (0)
- MP59-17 A MODEL OF HUMAN PENILE TRANSPLANTATION TO INVESTIGATE THE EFFECTS AND PATHOPHYSIOLOGY OF REJECTION AND CYCLOSPORIN A TREATMENT ON ERECTILE FUNCTION (2016) (0)
- PD03-07 A MULTI-INSTITUTIONAL EVALUATION OF RESCUE THERAPY WITH INTRAVESICAL GEMCITABINE AND DOCETAXOL FOR NON-MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE (2020) (0)
- Comparison of the ‘iROC’ trial participants to patients with bladder cancer in the United States undergoing radical cystectomy (2022) (0)
- REDUCED GENITAL BLOOD FLOW IN A RAT MODEL TO SIMULATE AUTONOMIC DYSFUNCTION AFTER NERVE SPARING RADICAL HYSTERECTOMY (2012) (0)
- Rapamycin Suppresses Penile NADPH Oxidase Activity to Preserve Erectile Function in Mice Fed a Western Diet (2021) (0)
- Feline penile erections induced by topical glans penis application of combination alprostadil and SEPA (Topiglan) (2004) (0)
- PD53-11 DIVERGENT THERAPEUTIC OUTCOMES OF STING AGONIST ADU-S100 IN INTRATUMORAL AND INTRAVESICAL TREATMENT REGIMENS IN SYNGENEIC MURINE MB49 AND IN THE N-METHYL-N-NITROSOUREA (MNU) RAT MODEL OF UROTHELIAL CARCINOMA (2022) (0)
- Reply: To PMID 25065987. (2014) (0)
- Comparison of responses to proadrenomedullary peptide (PAMP) and PAMP (12-20) in the mesenteric vascular bed of the CAT (1996) (0)
- PS-04-002 Increase in TNF-alpha leads to enhanced recruitment of neurotoxic M1 macrophages to the major pelvic ganglion following bilateral cavernous nerve injury (2016) (0)
- PD33-08 UTILITY OF URETHRAL FROZEN SECTIONS DURING RADICAL CYSTECTOMY FOR BLADDER CANCER (2016) (0)
- In vivo gene-transfer of calcitonin gene-related peptide (CGRP) reduces hypoxia-induced pulmonary hypertension in the mouse. (1999) (0)
- Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation (2022) (0)
- MP21-06 BLADDER SMOOTH MUSCLE CELLS UNDERGO A SYNTHETIC PHENOTYPE SWITCH IN A RAT MODEL OF NEUROGENIC UNDERACTIVE BLADDER DISEASE (2015) (0)
- Adenosine A1 receptors mediate vasodilation in the hindlimb vascular bed of the cat (1998) (0)
- PD13-06 EFFECT OF PHARMACOLOGIC PROPHYLAXIS ON VENOUS THROMBOEMBOLISM AFTER RADICAL PROSTATECTOMY: THE PREVENTER RANDOMIZED CLINICAL TRIAL (2020) (0)
- MP58-07 TUMOR PD-L1 AND LYMPHOCYTIC INFILTRATE FOXP3 STATUS IN NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF BLADDER (NMIBC) (2015) (0)
- Comparison of the Inhibitory Actions of Angiotensin AT1 Receptor Antagonists in the Peripheral Vascular Bed (1998) (0)
- 171 Increased Level of Tumor Necrosis Factor-alpha (TNFA) Leads to Downregulation of Nitrergic Neurons Following Bilateral Cavernous Nerve Injury and TNFA Inhibition Can Enhance Penile Smooth Muscle Relaxation by Upregulating Expression of Nitrergic Neurons (2020) (0)
- 1026 PELVIC NERVE INJURY LEADS TO AUGMENTED ADRENERGIC CONSTRICTION AND FIBROSIS OF THE DISTAL VAGINA (2013) (0)
- PD62-07 TUMOR NECROSIS FACTOR ALPHA (TNF- Α) INHIBITOR IMPROVED ERECTILE FUNCTION IN A BILATERAL CAVERNOUS NERVE INJURY RAT MODEL (2021) (0)
- Reply by Authors. (2020) (0)
- MP29-10 A NATIONALLY REPRESENTATIVE STUDY OF NON-INDEX HOSPITAL READMISSIONS FOLLOWING RADICAL PROSTATECTOMY: IMPLICATIONS FOR BUNDLED PAYMENT MODELS (2019) (0)
- 024 TNF-alpha Inhibits Neurite Outgrowth from the Major Pelvic Ganglion by Inducing Apoptosis of Nitrergic Neurons Ex Vivo (2016) (0)
- MP59-15 INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG NAÏVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER: UPDATES FROM A PHASE 2 TRIAL (2022) (0)
- Differential responses to 5-hydroxytryptamine in the hindquarter and mesenteric vascular beds of the cat (1999) (0)
- OP1-10 RHO-KINASE INHIBITION PREVENTS NNOS UNCOUPLING IN THE MPG, ERECTILE DYSFUNCTION AND INCREASES NEURONAL OUTGROWTH FOLLOWING CAVERNOUS NERVE INJURY (2014) (0)
- 1115 WHOLE GENOME MICROARRAY OF THE MAJOR PELVIC GANGLION AFTER CAVERNOUS NERVE INJURY: NEW INSIGHTS INTO EXPRESSION PROFILES AFTER NERVE INJURY (2011) (0)
- Overexpression of IGF1R to predict outcome in invasive urothelial carcinoma of urinary bladder. (2013) (0)
- Differential changes in self-reported quality of life in elderly populations after diagnosis of a genitourinary malignancy. (2022) (0)
- Operations for priapism (2012) (0)
- EPIGENETIC PRIMING WITH 5‐AZACITIDINE INCREASES SENSITIVITY OF BLADDER CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS: MP65‐20 (2017) (0)
- Reply: To PMID 26142586. (2015) (0)
- MP61-13 CAN THE RACIAL DISPARITY IN MORTALITY FOLLOWING CYSTECTOMY FOR UCC BE EXPLAINED? (2014) (0)
- 1429 OVEREXPRESSION OF IGF1R PREDICTS OUTCOME IN INVASIVE UROTHELIAL CARCINOMA OF URINARY BLADDER (2013) (0)
- Rising age, rising problems: the male lower genitourinary tract (2011) (0)
- Abstract 1551:GULP1is an epigenetically altered and functional tumor suppressor in urothelial carcinoma through regulation of Nrf2-Keap1 signaling axis (2017) (0)
- MP83-08 LOCAL T LYMPHOCYTE SUB-POPULATION RESPONSES TO INTRAVESICAL BCG AND CHEMOTHERAPY IN AN IMMUNE COMPETENT MURINE MODEL OF BLADDER CANCER (2016) (0)
- UROSEEK: A NOVEL NON‐INVASIVE MOLECULAR ASSAY FOR SURVEILLANCE OF BLADDER CANCER: MP65‐14 (2018) (0)
- PD42-06 INTERMEDIATE-TERM OUTCOMES IN MEN WITH VERY HIGH RISK PROSTATE CANCER (2016) (0)
- MP72-15 THE INTERVAL BETWEEN DIAGNOSIS AND RADICAL CYSTECTOMY DOES NOT IMPACT THE OUTCOMES OF PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY (2015) (0)
- 083 Critical Analysis of Human Amniotic Fluid as a Novel Biological Therapy (2019) (0)
- MP66-06 STING PATHWAY MOLECULES DO NOT PREDICT BCG RESPONSE IN NON-MUSCLE INVASIVE BLADDER CANCER (2021) (0)
- Abstract A32: Characterizing patterns of cytokine coexpression with immune checkpoint markers in CD4 and CD8 tumor-infiltrating lymphocytes (2020) (0)
- Seminar section introduction Metabolomics and urologic oncology (2011) (0)
- 915 NADPH-OXIDASE MEDIATED INACTIVATION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE CONTRIBUTES TO PRIAPISM IN TRANSGENIC SICKLE CELL MICE (2011) (0)
- Abstract 3689: Identification of candidate therapeutic targets in BCG unresponsive bladder cancer- inflammatory subtypes of BCG unresponsive bladder cancer (2018) (0)
- vascular responses Peroxynitrite does not impair pulmonary and systemic (2015) (0)
- Molecular Targets for Nitric Oxide Deficient Priapism (2016) (0)
- PS-3-5 Dendritic Cells and Cytotoxic T-Lymphocytes Driving the Inflammation in the Peyronie's Disease Micro-Environment (2020) (0)
- Reply: potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells (2007) (0)
- Does associated CIS with MIBC impact on neoadjuvant chemotherapy? Results of an International consortium (2017) (0)
- Tumor Immune Microenvironment in Response to Radiotherapy vs BCG in a Murine Model of Bladder Cancer (2020) (0)
- 130 Understanding Psychosocial and Sexual Health Concerns among Women with Bladder Cancer Undergoing Radical Cystectomy (2021) (0)
- 767 PATHOLOGICAL AND ONCOLOGIC OUTCOMES FOR MEN WITH POSITIVE LYMPH NODES AT RADICAL PROSTATECTOMY: 30-YEAR EXPERIENCE FROM A SINGLE INSTITUTION (2012) (0)
- Re: optimizing treatment for diabetes mellitus induced erectile dysfunction. (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Trinity Jude Bivalacqua?
Trinity Jude Bivalacqua is affiliated with the following schools:
